Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Panoro Energy (Oslo Ticker: PEN): Invitation to First Quarter 2019 conference call 23 May 2019

Panoro Energy’s Q1 2019 report will be published on Thursday, 23 May 2019 and will be available on our website http://www.panoroenergy.com at 07:30 a.m. CET. Panoro will hold a conference call at 09:00 a.m. CET on Thursday 23 May 2019, during which management will discuss Panoro's 2019 first quarter results. After conclusion of the discussion, participants invited to ask questions on the Q1 report. Participants are requested to dial in five to ten minutes prior to the start time using the numbers and password below: Local - Oslo, Norway +47 21 563 318Toll Free – Norway

Componenta to acquire Komas Oy and become the leading metal component manufacturer in Finland

Componenta Corporation Stock Exchange Release, Insider Information, 16 May 2019 at 8.00 Componenta Corporation (“Componenta”) has signed an agreement on purchasing the shares and capital loans of Komas Oy (“Komas”), a machining operation company, from funds managed by CapMan, Fortaco Oy and certain private persons. Komas is a manufacturer of machined components, forged blanks, hydraulic pipes and plate cuttings. In 2018, Komas had net sales EUR 44.9 million according to Finnish Accounting Standards (FAS) and EBITDA of EUR 2.0 million (FAS). At the end of 2018, the company employed 313

Ten winners at The Educators’ Challenge Awards

The Global Challenges Foundation are hosting The Educators’ Challenge Awards in London on May 15th. The award winners include various kinds of educators who have done an outstanding job of promoting positive action in regard to both global collaboration and global catastrophic risks.“The Educators’ Challenge Awards is part of our mission to explore how to effectively communicate and increase engagement among young people and the general public around global risks such as climate change, biological collapse and weapons of mass destruction,  which all require improved global cooperation,”

NEXT Biometrics and Newland Enter into Partnership Agreement to Deliver Biometric POS

Oslo, May 16, 2019 –NEXT Biometrics (Oslo Bors: NEXT), a global leader in fingerprint sensor technology, announces that it has entered into a supply agreement with Fujian Newland Payment Technology Co., Ltd. (Newland). Newland is the market-leading Point-of-Sale (POS) terminal manufacturer in China and ranks number two in the global POS sector according to The Nilson Report. The agreement provides for the integration of different types of NEXT Biometrics’ high-quality, large-area fingerprint sensors into a range of Newland`s POS terminals for sales on a global scale. The parties have

CLX Communications AB (publ): Invitation to conference call and web presentation of Sinch Q1 2019 interim report

Stockholm, Sweden – CLX Communications AB (publ) – XSTO: SINCH CLX Communications AB will publish its 2019 first quarter interim report on Friday, May 17, 2019, at 07:30 AM CET. You are invited to participate in a conference call at 09:00 AM CET on the same day. Oscar Werner, CEO, and Roshan Saldanha, CFO, will present the report and review the results. Time for publication of the interim reportFriday May 17, 2019, at 07:30 AM CET Time for conference call and web presentationFriday May 17, 2019, at 09:00 AM CET Dial-in numbers and access codePlease make sure you are

YIT construction industry´s most attractive employer for students

YIT Corporation Press release, May 16, 2019, at 7 a.m.Technology students ranked YIT as the most ideal construction industry employer in Universum’s Student Survey. YIT also improved its ranking in the list of ideal technology employers: the company was ranked 5th, which is YIT’s best ranking so far in this list. Every year, YIT offers diverse summer jobs and work placements to about 1,000 young people in the spirit of doing things together. Traditionally, student employees spend the summer at YIT learning the ropes and putting the teachings of their construction studies into practice.

NGEx Reports First Quarter 2019 Results

VANCOUVER, May 15, 2019 /CNW/: NGEx Resources Inc. (TSX: NGQ) (NASDAQ STOCKHOLM: NGQ) (“NGEx” or the “Company”) is pleased to announce its results for the three months ended March 31, 2019. HIGHLIGHTS · On April 17, 2019, the Company announced its intention to spin out its Los Helados Project and exploration portfolio into a wholly-owned subsidiary of NGEx, 11264796 Canada Inc. (“Spinco”) through a Plan of Arrangement under the Canada Business Corporations Act (the “Arrangement”). The Arrangement is designed to deliver greater value to shareholders by unlocking the value of the Los

Cantargia: abstract published for the oral presentation of antibody CAN04 phase I data at ASCO

Cantargia AB today announces that the abstract of the upcoming oral presentation of CAN04 phase I clinical data at the 2019 ASCO Annual Meeting is published on the conference website. The abstract reports available data on the 22 patients in the phase I trial based on the interim analysis performed in February 2019. These data show that the safety profile of CAN04 was good and that CAN04 treatment led to a decrease of the biomarkers IL-6 and CRP already after two weeks of therapy. Nine patients had stable disease as determined by irRC after eight weeks follow up. One patient with pancreatic

Alligator Bioscience: ADC-1013 clinical Phase I data to be presented at ASCO

Lund, Sweden, May 15, 2019 – Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces that Janssen Biotech, Inc. (Janssen) will present data from a Phase I clinical study of ADC-1013 (JNJ-7107) at the upcoming ASCO Annual meeting held in Chicago on May 31- June 4. The study results show that side effects were generally mild and transient. The primary aim of the study was safety and to establish a recommended dose for Phase II. The study is still ongoing and has enrolled a total of 95 patients. The maximum tolerated dose has not yet been reached. Doses up to 1200 μg/kg i.v without

BerGenBio to present new NSCLC and AML clinical data and biomarker data from Phase II development programme with selective AXL inhibitor bemcentinib at ASCO 2019

· Two peer reviewed abstracts on Phase II clinical data with bemcentinib accepted for presentation at ASCO 2019 · Non-Small-Cell Lung Cancer (NSCLC) trial of bemcentinib in combination with pembrolizumab, data to be presented includes safety, response rates and overall survival · Acute Myeloid Leukaemia (AML) trial of bemcentinib in combination with low dose AraC chemotherapy or decitabine reported safety and rapid, durable complete response ratesBergen, Norway, 15 May 2019 – BerGenBio ASA (OSE: BGBIO) a clinical-stage biopharmaceutical company developing novel, selective AXL kinase

Oncopeptides Announces Melflufen Data Accepted for Presentation at 2019 ASCO Annual Meeting

Stockholm – May 15, 2019 – Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that data from its Phase 1/2 O-12-M1 study evaluating melflufen, a lipophilic peptide-conjugated alkylator belonging to the novel class of peptidase enhanced cytotoxics, in the treatment of relapsed/refractory multiple myeloma (RRMM) have been selected for poster presentation at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting taking place May 31 – June 4 in Chicago.The data offers an analysis of time to next treatment (TTNT) in patients with RRMM who were treated with melflufen and

Grant of share options to primary insiders in Atea ASA

On 15 May 2019, key employees in the Atea Group were granted share options in Atea ASA. The following primary insiders were granted options (in alphabetic order, by last name): Arunas Bartusevicius (Managing Director, Atea Baltics) has been granted 70,000 options vesting on December 15, 2022. Following the grant, Arunas Bartusevicius holds 260,000 options and 100,194 shares in Atea ASA. August Baumann (Senior Vice President, Atea ASA) has been granted 70,000 options vesting on December 15, 2022. Following the grant, August Baumann holds 280,000 options and 2,200 shares in Atea ASA.

Decisions taken by Altia’s Annual General Meeting 2019 and Altia’s Board of Directors

Altia Plc Stock Exchange Release 15 May 2019 at 8:45 pm EET  Decisions taken by Altia’s Annual General Meeting 2019 and Altia’s Board of Directors  Altia’s Annual General Meeting was held in Helsinki on 15 May 2019. The meeting adopted the financial statements and discharged the members of the Board of Directors and the CEO from liability for the financial year 2018.   Dividend payment  The meeting approved the proposal by the Board of Directors to pay a dividend of EUR 0.38 per share. The dividend will be paid on 24 May 2019 to a shareholder registered in the shareholders’

Demerger Flakk Composites AS

On 15.05.2019, the board of directors of Flakk Composites AS resolved to propose to its shareholders meeting that Flakk Composites AS shall demerger certain assets to two entities to be incorporated as part of the demerger, included in which are 25 000 000 shares in Hexagon Composites ASA. Flakk Composites AS is wholly owned by Flakk Gruppen AS, a company owned 98.7% by Knut Flakk, chairman of the board of Hexagon Composites ASA. Flakk Composites AS will change its name to Flakk Rollon AS as part of the demerger.After, and subject to, completion of the demerger Flakk Rollon AS will hold 4

Resolutions at GARO Aktiebolag’s Annual General Meeting 2019

At the Annual General Meeting of GARO Aktiebolag held on 15 May 2019, the following was resolvedElection of Board of Directors Stefan Jonsson (Chairman), Rickard Blomqvist, Susanna Hilleskog, Per Holmstedt and Lars-Åke Rydh were re-elected and Mari-Katharina Jonsson Kadowaki was elected as new member of the Board. Lars Svensson had declined re-election. Fees to the Board of Directors It was resolved that Board fees shall be paid by SEK 470,000 to the Chairman of the Board and SEK 210,000 to each of the Board members elected by the AGM. It was further resolved that fees for

Nuevolution AB (publ) announces timing for the release and webcast of the first quarter 2019 interim results

Stockholm, 15 May 2019 – Nuevolution AB (publ) (NUE.ST) announces today that it will report its interim report for the first quarter 2019 on Wednesday, 22 May 2019 after 18:00 CET. On Thursday, 23 May 2019 at 15:00 CET, the company’s executive management will host a conference call and webcast discussion of the results and provide an update on the pipeline programs and partnering activities. Access to the event can be obtained as follows: LIVE access on Thursday 23 May at 15:00 CET Telephone numbers: SE: +46 85 05 58 352 DK: +45 7815 0108 UK: +44 33 3300 9030 US: +1 833

SSM to focus on core business – intends to divest contracting operations and enter into a strategic partnership with Mecon

SSM Holding AB (publ), Sweden’s leading developer of smart, affordable homes, intends to carry out strategic measures to strengthen the company’s long-term competitiveness and profitability.  The company intends to focus its core operations on business and project development, sales and aftermarket and at the same time initiate a strategic partnership with Mecon Bygg AB, a contracting company specialized in cost-efficient design-build contracts for multi-dwelling housing. As a result, SSM and Mecon are discussing transferring SSM's construction operations to Mecon. SSM will now start

Report from ÅF Pöyry's Annual General Meeting 2019

Press release from ÅF Pöyry, May 15, 2019 For further information:Rickard Dahlgren, Associate General Counsel, +46 10 50 50 446On Wednesday May 15, 2019, ÅF Pöyry AB (publ)’s annual general meeting was held at the group’s headquarters in Solna, Sweden. Adoption of the Income Statement and the Balance SheetThe meeting adopted the income statements and balance sheets for the Group and the parent company for 2018. The members of the Board of Directors and the President were discharged from liability for the fiscal year 2018. DividendThe proposed dividend of SEK 5 per share was

Bulletin from the annual general meeting of Vicore Pharma Holding AB (publ)

The following resolutions were passed at the annual general meeting (the “AGM”) of Vicore Pharma Holding AB (publ) (”Vicore Pharma”) on 15 May 2019.Adoption of income statement and balance sheet for the financial year 2018 and discharge from liability The AGM resolved to adopt the income statement and the consolidated income statement for the financial year 2018 as well as the balance sheet and consolidated balance sheet as of 31 December 2018. The members of the board of directors and the managing director were discharged from liability for the financial year 2018. Allocation of

12 California Inns with Extraordinary Gardens

SACRAMENTO, CA [May 15, 2019]—In addition to their well-appointed rooms, delightful breakfasts, and uncompromising hospitality, bed and breakfast inns are just as often known for their vibrant gardens. The California Association of Boutique & Breakfast Inns (CABBI) has compiled a list of inns around the Golden State with a profusion of unique blooms and welcoming, intimate spaces. Known for drama, exuberance, and year-round color, the gardens at Half Moon Bay’s Mill Rose Inn  have been described as “extravagant” by the San Francisco Chronicle and as

Bulletin from Moberg Pharma’s AGM 2019

STOCKHOLM, May 15th, 2019. Moberg Pharma AB’s (“Company”) Annual General Meeting took place on Wednesday, May 15th, 2019 in the Company´s premises in Bromma, Sweden.Adoption of the income statements and the balance sheetsThe Annual General Meeting (the “Meeting”) approved the income statements and the balance sheets for the fiscal year 2018. The Meeting resolved, in accordance with the proposal of the Board of Directors, that no dividend should be paid for the fiscal year 2018. The Meeting discharged the Board members and the Chief Executive Officer from liability for the fiscal

Communiqué from annual general meeting in ChromoGenics AB (publ)

The annual general meeting in ChromoGenics AB (publ) was held on 15 May 2019 at Advokatfirman Lindahl’s offices on Vaksalagatan 10 in Uppsala whereby the shareholders resolved on the following main matters.Annual report and profit and loss statement The annual general meeting adopted the presented profit and loss statement and the balance sheet and resolved, in accordance with the board of directors’ proposal, to carry the accumulated loss forward in new account. No dividends will be paid for the financial year 2018. Discharge from liability The board of directors and the managing

Press release from Extraordinary General Meeting of Cereno Scientific AB (publ)

An Extraordinary General Meeting of Cereno Scientific AB (“Cereno”) was held today, 15 May 2019, at the offices of GU Ventures at Erik Dahlbergsgatan 11 in Gothenburg, Sweden. A summary of the resolutions made is presented below. All resolutions were unanimous.Resolution on changes to the Articles of Association The Meeting resolved, in accordance with the proposal from the Board of Directors, to adopt new Articles of Association with amended limits for share capital and the number of shares, as a result of which the Articles of Association have been amend as follows. Article 4 –

There are no items matching the current filter
There are no more items matching the current filter
Back to top